Buchumschlag

Implications of the shift to DSM‐5 for alcohol use disorder prevalence estimates in the National Survey on Drug Use and Health

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Allen J. Bailey, Patrick D. Quinn, R. Kathryn McHugh
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Addiction
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Associations between modes of cannabis use and cannabis use disorder: Evidence from the 2022 to 2023 United States National Survey on Drug Use and Health
von: Amrit Baral, et al.
Veröffentlicht: (2026)

Substance use and sexual orientation among adolescents: Differences by age group and sex in the 2023 National Survey of Drug Use and Health
von: Timothy J. Grigsby, et al.
Veröffentlicht: (2025)

Examining the moderating role of cannabis use on the relationship between alcohol consumption and inflammation in individuals with alcohol use disorder
von: Erica N. Grodin, et al.
Veröffentlicht: (2024)

Neural responses to stress and alcohol cues in individuals with pain with and without alcohol use disorder
von: Milena Radoman, et al.
Veröffentlicht: (2024)

Health and economic impact of universal screening and management of alcohol use disorders in India: An economic modelling study
von: Neha Purohit, et al.
Veröffentlicht: (2026)

Efficacy of a personalised alcohol approach bias modification smartphone app in people accessing outpatient alcohol use disorder treatment: A randomised controlled trial
von: Joshua B. B. Garfield, et al.
Veröffentlicht: (2025)

Systematic review of symptom‐level networks of alcohol use disorder
von: Eve Oostendorp, et al.
Veröffentlicht: (2025)

Impact of bariatric surgery on alcohol‐use disorder and alcohol‐related liver disease: A retrospective study
von: Thomas J. Williams, et al.
Veröffentlicht: (2026)

Commentary on Andreacchi et al.: Policy responses to shifting epidemiological trends in alcohol use in Canada
von: Carolin Kilian, et al.
Veröffentlicht: (2024)

Recovery support services as part of the continuum of care for alcohol or drug use disorders
von: Ed Day, et al.
Veröffentlicht: (2025)

RETRACTION: Proportions and Correlates of High‐Risk Cannabis Use in Australia—A Cross‐Sectional Analysis of the 2022–2023 National Drug Strategy Household Survey
Veröffentlicht: (2026)

Patterns, reasons and characteristics of e‐cigarette use in Australia: Findings from the 2022–2023 National Drug Strategy Household Survey
von: Carmen C. W. Lim, et al.
Veröffentlicht: (2025)

Alcohol use and alcohol use disorders in sub‐Saharan Africa: A systematic review and meta‐analysis
von: Habte Belete, et al.
Veröffentlicht: (2024)

Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double‐blind, placebo‐controlled trial
von: Henri‐Jean Aubin, et al.
Veröffentlicht: (2024)

The prevalence of substance use disorders among people in Norwegian, Danish and Swedish prisons: A multi‐national cohort study, 2010–19
von: Anne Bukten, et al.
Veröffentlicht: (2024)

Microglia activity in the human basal ganglia is altered in alcohol use disorder and reversed with remission from alcohol
von: Ameer Elena Rasool, et al.
Veröffentlicht: (2024)

5‐Methoxy‐ N , N ‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial
von: John Marsden, et al.
Veröffentlicht: (2025)

Daily or near‐daily cannabis and alcohol use by adults in the United States: A comparison across age groups
von: Megan E. Patrick
Veröffentlicht: (2024)

Medication effects on cue‐induced craving in the human laboratory are associated with return to heavy drinking in randomized clinical trials for alcohol use disorder: A follow‐up meta‐analysis
von: Steven J. Nieto, et al.
Veröffentlicht: (2026)

Changes in alcohol‐related social network composition mediate the effects of AA meeting attendance on drinking following a recovery attempt in adults with alcohol use disorder
von: Emily E. Levitt, et al.
Veröffentlicht: (2025)

RETRACTED: Proportions and correlates of high‐risk cannabis use in Australia—A cross‐sectional analysis of the 2022–2023 National Drug Strategy Household Survey
von: Janni Leung, et al.
Veröffentlicht: (2025)

Socio‐economic differences in the effectiveness of pharmacotherapy use in alcohol use disorder: A cohort study of 148 626 individuals in Sweden
von: Devy L. Elling, et al.
Veröffentlicht: (2025)

Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study
von: María Salud García‐Gutiérrez, et al.
Veröffentlicht: (2025)

Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial
von: Amandine Luquiens, et al.
Veröffentlicht: (2025)

Could alcohol‐free and low‐alcohol beverages be used to extinguish alcohol cravings?
von: Molly A. Bowdring
Veröffentlicht: (2025)

Efficacy and safety of transcranial direct current stimulation in alcohol use disorder: A randomized controlled triple‐blind trial
von: Benoit Trojak, et al.
Veröffentlicht: (2026)

The potential of 5‐methoxy‐N,N‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action
von: Stephan C. Tap
Veröffentlicht: (2024)

Global, interhemispheric and intrahemispheric functional connection patterns in male adults with alcohol use disorder
von: Yarui Wei, et al.
Veröffentlicht: (2024)

Neural response to threat and reward among young adults at risk for alcohol use disorder
von: Katelyn T. Kirk‐Provencher, et al.
Veröffentlicht: (2024)

Daily associations between sleep and alcohol use among veterans: Acute and cumulative effects
von: Mary Beth Miller, et al.
Veröffentlicht: (2025)

Increased white blood cell in young adults with family histories of alcohol and other substance use disorders
von: Mustafa N. Mithaiwala, et al.
Veröffentlicht: (2024)

Commentary on Aubin et al.: Could combination medication approaches target mental health comorbidity in the context of alcohol use disorder?
von: Shalini Arunogiri, et al.
Veröffentlicht: (2024)

Glucagon‐like peptide‐1 receptor agonists in alcohol use disorder: Multi‐system effects, early clinical promise and uncertain long‐term use
von: Carolina L. Haass‐Koffler
Veröffentlicht: (2026)

Does alcohol use and related harm differ based on the age of initiation to alcohol? Results from a prospective cohort study
von: Philip J. Clare, et al.
Veröffentlicht: (2025)

Examining changes in the prevalence of cost‐motivated alcohol reduction attempts in the context of a cost‐of‐living crisis and alcohol duty reforms: A population survey of risky drinkers in Great Britain, 2021–2024
von: Sarah E. Jackson, et al.
Veröffentlicht: (2025)

Non‐alcoholic beverage consumption among US adults who consume alcohol
von: Molly A. Bowdring, et al.
Veröffentlicht: (2024)

Commentary on Dowd et al .: Beyond single data sources—Consistency checking and evidence synthesis for prevalence estimation
von: Hayley E. Jones, et al.
Veröffentlicht: (2026)

Distributions of alcohol use and alcohol‐caused death and disability in Canada: Defining alcohol harm density functions and new perspectives on the prevention paradox
von: Adam Sherk, et al.
Veröffentlicht: (2024)

The association between adverse childhood experiences and alterations in brain volume and cortical thickness in adults with alcohol use disorder
von: Cagdas Türkmen, et al.
Veröffentlicht: (2024)

The prevalence of cannabidiol (CBD) use in North America and Europe: A meta‐analysis
von: Sara Weidberg, et al.
Veröffentlicht: (2026)